GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce the DEA has Rescheduled EPIDIOLEX (cannabidiol) Oral Solution to Schedule V
GW Pharmaceuticals Announces Preliminary Results of Phase 2a Study for its Pipeline Compound GWP42006
Silver Hammer Announces Acquisitions of Stroud Resources and Silvermark Resources and Brokered Financing; Eric Sprott to Become Cornerstone Shareholder
QIMC Reports Record 24.3% Clean Natural Hydrogen at Bennett Hill DDH-26-04 and Begins Technical Evaluation of Pilot-Scale Development Pathway and Clean Energy Generation
